Location History:
- New South Wales, AU (2016 - 2018)
- Frenchs Forest, AU (2020 - 2021)
Company Filing History:
3 out of 1,536 
3 out of 7 
2 out of 3 Years Active: 2016-2025
Title: Innovations of Wolfgang Jarolimek
Introduction
Wolfgang Jarolimek is a notable inventor based in Frenchs Forest, Australia. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target various neuromuscular and neuroinflammatory diseases. With a total of 8 patents to his name, his work has the potential to impact both human and animal health.
Latest Patents
One of his latest patents is focused on "Haloallylamine dual amine oxidase inhibitors." This invention relates to novel compounds capable of inhibiting semicarbazide-sensitive amine oxidase (SSAO/VAP-1) and monoamine oxidase B (MAO-B). These compounds are useful for treating a variety of neuromuscular diseases, such as muscular dystrophies, and neuroinflammatory diseases, including both peripheral and central disorders in human subjects, as well as in pets and livestock. Additionally, this patent includes pharmaceutical compositions containing these compounds and various uses thereof.
Another significant patent is for "Haloallylamine sulfone derivative inhibitors of lysyl oxidases and uses thereof." This invention also relates to novel compounds that inhibit certain amine oxidase enzymes. These compounds are beneficial for treating various conditions, including fibrosis, cancer, and angiogenesis in both human subjects and animals. Similar to his previous patent, this one also encompasses pharmaceutical compositions and their various applications.
Career Highlights
Wolfgang Jarolimek has worked with prominent companies in the pharmaceutical industry, including Boehringer Ingelheim International GmbH and Pharmaxis Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Throughout his career, Wolfgang has collaborated with notable professionals in the field, including Mandar Deodhar and Alison Dorothy Findlay. These collaborations have likely enriched his research and development efforts.
Conclusion
Wolfgang Jarolimek's innovative work in pharmaceutical sciences demonstrates his commitment to advancing treatments for neuromuscular and neuroinflammatory diseases. His contributions through patents and collaborations highlight the importance of innovation in improving health outcomes for both humans and animals.